- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Volume 2012 (2012), Article ID 691380, 8 pages
Recent Trends in Prostate Cancer Incidence by Age, Cancer Stage, and Grade, the United States, 2001–2007
1Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, CDC,
4770 Buford Hwy, MS K55, Atlanta, GA 30341, USA
2Department of Urology and Winship Cancer Institute, School of Medicine, Emory University, 1365C Clifton Road, Atlanta, GA 30322, USA
Received 22 August 2012; Revised 25 October 2012; Accepted 31 October 2012
Academic Editor: J. W. Moul
Copyright © 2012 Jun Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Citations to this Article [33 citations]
The following is the list of published articles that have cited the current article.
- H. Ballentine Carter, “American Urological Association (AUA) Guideline on prostate cancer detection: process and rationale,” BJU International, vol. 112, no. 5, pp. 543–547, 2013.
- Daniel A Barocas, Vivien Chen, Matthew Cooperberg, Michael Goodman, John J Graff, Sheldon Greenfield, Ann Hamilton, Karen Hoffman, Sherrie Kaplan, Tatsuki Koyama, Alicia Morgans, Lisa E Paddock, Sharon Phillips, Matthew J Resnick, Antoinette Stroup, Xiao Cheng Wu, and David F Penson, “Using a population-based observational cohort study to address difficult comparative effectiveness research questions: the CEASAR study,” Journal of Comparative Effectiveness Research, vol. 2, no. 4, pp. 445–460, 2013.
- H. Ballentine Carter, Peter C. Albertsen, Michael J. Barry, Ruth Etzioni, Stephen J. Freedland, Kirsten Lynn Greene, Lars Holmberg, Philip Kantoff, Badrinath R. Konety, Mohammad Hassan Murad, David F. Penson, and Anthony L. Zietman, “Early Detection of Prostate Cancer: AUA Guideline,” The Journal of Urology, 2013.
- D. Le Broc-Ryckewaert, R. Carpentier, E. Lipka, S. Daher, C. Vaccher, D. Betbeder, and C. Furman, “Development of innovative paclitaxel-loaded small PLGA nanoparticles: Study of their antiproliferative activity and their molecular interactions on prostatic cancer cells,” International Journal of Pharmaceutics, 2013.
- Hiten D. Patel, Elizabeth Humphreys, Bruce J. Trock, Misop Han, and H. Ballentine Carter, “Practice Patterns and Individual Variability of Surgeons Performing Radical Prostatectomy at a High Volume Academic Center,” The Journal of Urology, 2014.
- Marianne Schmid, Qd Quoc-Dien Trinh, Markus Graefen, Margit Fisch, Felix K. Chun, and Jens Hansen, “The role of biomarkers in the assessment of prostate cancer risk prior to prostate biopsy: Which markers matter and how should they be used?,” World Journal of Urology, vol. 32, no. 4, pp. 871–880, 2014.
- Bryan Hoang, Mark J. Ernsting, Mami Murakami, Elijus Undzys, and Shyh-Dar Li, “Docetaxel-carboxymethylcellulose nanoparticles display enhanced anti-tumor activity in murine models of castration-resistant prostate cancer,” International Journal of Pharmaceutics, vol. 471, no. 1-2, pp. 224–233, 2014.
- Chunkit Fung, William Dale, and Supriya Gupta Mohile, “Prostate Cancer in the Elderly Patient,” Journal of Clinical Oncology, vol. 32, no. 24, pp. 2523–2530, 2014.
- Hideyuki Akaza, Choung Soo Kim, Peter Carroll, In Young Choi, Byung Ha Chung, Matthew R. Cooperberg, Yoshihiko Hirao, Shiro Hinotsu, Shigeo Horie, Ji Youl Lee, Mikio Namiki, Chi-Fai Ng, Mizuki Onozawa, Seiichiro Ozono, Satoru Ueno, Rainy Umbas, Dingwei Ye, and Gang Zhu, “Seventh Joint Meeting of K-J-CaP and CaPSURE: extending the global initiative to improve prostate cancer management,” Prostate International, vol. 2, no. 2, pp. 50–69, 2014.
- Dae-Seon Yoo, Seung Hyo Woo, Seok Cho, Seok Ho Kang, Sang Jin Kim, Sung Yul Park, Sang Hyub Lee, Seung Hyun Jeon, and Jinsung Park, “Practice Patterns of Urologists in Managing Korean Men Aged 40 Years or Younger With High Serum Prostate-specific Antigen Levels,” Urology, 2014.
- Berat Cem Özgür, Ersin Köseoğlu, Ali İhsan Arık, Haşmet Sarıcı, Övünç Bilgin, Cem Nedim Yücetürk, Elif Özer, Eşref Oğuz Güven, Onur Telli, Ali Atan, and Muzaffer Eroğlu, “Synchronous bladder and prostate cancers in the specimens of radical cystoprostatectomy: A multicenter retrospective analysis,” The Kaohsiung Journal of Medical Sciences, 2014.
- Michael P. Hoeh, and Leslie A. Deane, “PSA Screening: A Discussion Based on the USPSTF Recommendations and the AUA and EAU Guidelines,” Journal of Mens Health, vol. 11, no. 1, pp. 10–17, 2014.
- Sankar N Krishna, and Raymond C Bergan, “Therapeutic modulation of prostate cancer metastasis,” Future Medicinal Chemistry, vol. 6, no. 2, pp. 223–239, 2014.
- Francesco Ricci, Giulia Buzzatti, Alessandra Rubagotti, and Francesco Boccardo, “Safety of antiandrogen therapy for treating prostate cancer,” Expert Opinion on Drug Safety, vol. 13, no. 11, pp. 1483–1499, 2014.
- Mizuki Onozawa, Shiro Hinotsu, Taiji Tsukamoto, Mototsugu Oya, Osamu Ogawa, Tadaichi Kitamura, Kazuhiro Suzuki, Seiji Naito, Mikio Namiki, Kazuo Nishimura, Yoshihiko Hirao, and Hideyuki Akaza, “Recent Trends in the Initial Therapy for Newly Diagnosed Prostate Cancer in Japan,” Japanese Journal of Clinical Oncology, vol. 44, no. 10, pp. 969–981, 2014.
- Adam M. Hirst, Fiona M. Frame, Norman J. Maitland, and Deborah O’Connell, “Low Temperature Plasma: A Novel Focal Therapy for Localized Prostate Cancer?,” BioMed Research International, vol. 2014, pp. 1–15, 2014.
- Shinobu Watanabe-Galloway, Kate Watkins, and Tinka Duran, “Trends and Patterns of Late and Unstaged Lung, Colorectal, Female Breast, and Prostate Cancers among American Indians in the Northern Plains, 2002-200,” Journal Of Health Care For The Poor And Underserved, vol. 26, no. 3, pp. 1048–1066, 2015.
- Mostafa Mohamed Mostafa Elian, Enas Ahmed Abdel Gawad, and Tarek K.H. Fathelbab, “Value of functional MRI in evaluation of patients with suspected prostate cancer,” The Egyptian Journal of Radiology and Nuclear Medicine, 2015.
- Chad A. Reichard, Andrew J. Stephenson, and Eric A. Klein, “Applying precision medicine to the active surveillance of prostate cancer,” Cancer, 2015.
- R. Yang, F. Fang, J. Wang, and H. Guo, “Adipose-derived stem cells ameliorate erectile dysfunction after cavernous nerve cryoinjury,” Andrology, vol. 3, no. 4, pp. 694–701, 2015.
- Neil Mendhiratta, Ted Lee, Vinay Prabhu, Elton Llukani, and Herbert Lepor, “10-Year Mortality After Radical Prostatectomy for Localized Prostate Cancer in the Prostate-specific Antigen Screening Era,” Urology, 2015.
- Jieke Yan, Yuzhen Wang, Xufeng Zhang, Shuangde Liu, Chuan Tian, and Hongwei Wang, “ Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid–polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo ,” Drug Delivery, pp. 1–6, 2015.
- Camella J Rising, Nadine Bol, and Gary L Kreps, “Age-Related Use and Perceptions of eHealth in Men With Prostate Cancer: A Web-Based Survey,” JMIR Cancer, vol. 1, no. 1, pp. e6, 2015.
- Asha Singanamalli, Mirabela Rusu, Rachel E. Sparks, Natalie N.C. Shih, Amy Ziober, Li-Ping Wang, John Tomaszewski, Mark Rosen, Michael Feldman, and Anant Madabhushi, “Identifying in vivo DCE MRI markers associated with microvessel architecture and gleason grades of prostate cancer,” Journal of Magnetic Resonance Imaging, 2015.
- William Tabayoyong, and Robert Abouassaly, “Prostate Cancer Screening and the Associated Controversy,” Surgical Clinics of North America, 2015.
- Jiao Li, Si Zheng, Bin Chen, Atul J. Butte, S. Joshua Swamidass, and Zhiyong Lu, “A survey of current trends in computational drug repositioning,” Briefings in Bioinformatics, vol. 17, no. 1, pp. 2–12, 2015.
- Hannah K. Weir, Trevor D. Thompson, Ashwini Soman, Bjørn Møller, and Steven Leadbetter, “The past, present, and future of cancer incidence in the United States: 1975 through 2020,” Cancer, 2015.
- Jun Guo, Shu-Hong Wu, Wei-Guo Ren, Xin-Li Wang, and Ai-Qing Yang, “Anticancer activity of bicalutamide-loaded PLGA nanoparticles in prostate cancers,” Experimental And Therapeutic Medicine, vol. 10, no. 6, pp. 2305–2310, 2015.
- Yao Zhu, Hong-Kai Wang, Yuan-Yuan Qu, and Ding-Wei Ye, “Prostate cancer in East Asia: evolving trend over the last decade,” Asian Journal Of Andrology, vol. 17, no. 1, pp. 48–57, 2015.
- Wan Song, and Hwang Gyun Jeon, “Incidence of kidney, bladder, and prostate cancers in Korea: An update,” Korean Journal of Urology, vol. 56, no. 6, pp. 422, 2015.
- Long-Bin Cao, Sha Zeng, and Wei Zhao, “Highly Stable PEGylated Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for the Effective Delivery of Docetaxel in Prostate Cancers,” Nanoscale Research Letters, vol. 11, no. 1, 2016.
- Richard M. Hoffman, Angela L. W. Meisner, Wadih Arap, Marc Barry, Satyan K. Shah, Steven B. Zeliadt, and Charles L. Wiggins, “Trends in United States Prostate Cancer Incidence Rates by Age and Stage, 1995-2012,” Cancer Epidemiology Biomarkers & Prevention, vol. 25, no. 2, pp. 259–263, 2016.
- Brian R. Hu, Adrian S. Fairey, Anisha Madhav, Dongyun Yang, Meng Li, Susan Groshen, Craig Stephens, Philip H. Kim, Navneet Virk, Lina Wang, Sue Ellen Martin, Nicholas Erho, Elai Davicioni, Robert B. Jenkins, Robert B. Den, Tong Xu, Yucheng Xu, Inderbir S. Gill, David I. Quinn, and Amir Goldkorn, “ AXIN2 expression predicts prostate cancer recurrence and regulates invasion and tumor growth ,” The Prostate, 2016.